COVID Vaccine Recommendations

Order byBest matchMost fresh

FDA, COVID

FDA offers new guidelines to shift COVID vaccine focus to high-risk groups

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over the age of 65 years and for all persons above the age of 6 months with one...

· 3h · on MSN

FDA sets new COVID booster guidelines for healthy adults under 65

· 7h

Doctor on FDA announcement of changes to COVID-19 vaccination guidelines

· 9h

US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant

The U.S. Senate plans to vote this week to bar California's landmark plan to end the sale of gasoline-only vehicles by 2035 that has been adopted by 11 other states, Majority Leader John Thune said on...

· 12h

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved

· 13h

US regulators say annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved

· 8h

FDA plans to limit COVID vaccine to only high-risk people. Florida cases, deaths in 2025

Public trust in vaccination has declined, potentially impacting other vital immunization programs.

· 5h

New FDA rule could delay Covid vaccine rollout for healthy adults and kids

· 6h

F.D.A. Poised to Restrict Access to Covid Vaccines

5hon MSN

Mass. residents say they're not worried by new COVID vaccine guidelines

New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get at least one vaccine per year, with those in higher-0

8hon MSN

FDA Changes How COVID Vaccines Will Be Approved—Here’s What To Know

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new commissioner described as a “one-size-fits-all regulatory framework.”

COVID vaccine guidelines, D-Wave, Viking Cruises: Trending Tickers

The US Food and Drug Administration (FDA) announces new regulatory guidelines for future COVID-19 vaccines and booster shots. Moderna (MRNA) and Pfizer (PFE) shares move higher on this news, while Novavax (NVAX) takes a dip.

Trump Administration Releases New COVID-19 Vaccine Plan: What to Know

In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well as children and younger adults who have one or more risk factors that make them more vulnerable to severe COVID-19.

5hon MSN

MAHA Influencer Slams Trump Admin COVID Vaccine Update—'Really Unfortunate'

"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.

CIDRAP8h

FDA significantly limits COVID-19 vaccine recommendations

The US Food and Drug Administration (FDA) announced today that it will only recommend COVID-19 vaccines for adults 65 and older and people at risk for severe illness. In a marked departure from the current recommendations of seasonal vaccination for anyone 6 months and older,

Federal Officials May Limit Recommendations for Covid Vaccine

With new testing requirements, it’s not even clear whether new Covid or flu shots can be made available this fall.

12hon MSN

FDA to limit future Covid-19 shots to older people and those at risk of serious infection

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit future vaccines to older Americans and people at higher risk of serious Covid-19 infection.